Esalen is open!

Starting Friday May 17 at 6:30 a.m., Highway 1 north of Esalen will reopen with the use of a 24/7 signalized traffic control, providing unrestricted public access with one-way alternating traffic in both the north and southbound directions. Please plan travel accordingly to accommodate a brief delay of up to 10-15 minutes at the traffic control site.

Highway 1 south of Esalen remains closed. Guests traveling from points south of us, please take the alternate route through Monterey.

Learn more.

Learn more.

Due to road closures along Highway 1 to our north and south, Esalen is closed through April 11.
Esalen Institute is open! However, Highway 1 to the south is closed — please review the alternate route directions.

Esalen opens May 3, 2024

Visitors are now able to access Esalen as well as other businesses and trails in northern Big Sur via twice-daily convoys on Highway 1 operated by Caltrans.

Convoys run only at 7:00 a.m. and 5:00 p.m. each day. These are the only opportunities to travel into and out of Big Sur, so visitors must plan accordingly.

Learn more.

Robin Carhart-Harris, Ph.D

Dr. Robin Carhart-Harris obtained his PhD in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University. At his current post at the Imperial College London, Robin designed human brain imaging studies with LSD, psilocybin, MDMA and DMT. His areas of research also include a clinical trial of psilocybin for treatment-resistant depression, an ongoing trial comparing psilocybin with escitalopram for major depressive disorder and a multimodal imaging study in healthy volunteers receiving psilocybin for the first time. Robin founded and heads the Centre for Psychedelic Research at Imperial, the first of its kind in the world. He holds an honorary position with the University of Oxford.

Featured Content

No items found.
Featured Content
No items found.

Robin Carhart-Harris, Ph.D

Dr. Robin Carhart-Harris obtained his PhD in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University. At his current post at the Imperial College London, Robin designed human brain imaging studies with LSD, psilocybin, MDMA and DMT. His areas of research also include a clinical trial of psilocybin for treatment-resistant depression, an ongoing trial comparing psilocybin with escitalopram for major depressive disorder and a multimodal imaging study in healthy volunteers receiving psilocybin for the first time. Robin founded and heads the Centre for Psychedelic Research at Imperial, the first of its kind in the world. He holds an honorary position with the University of Oxford.

Website

Upcoming Workshops

No items found.
No upcoming workshops.

Past Workshops

Featured Content

No items found.